Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

BACKGROUND: Little is known about the safety and efficacy of concurrent capecitabine and stereotactic radiotherapy in the setting of breast cancer brain metastases (BCBM). METHODS: Twenty-three patients with BCBM underwent 31 stereotactic sessions to 90 lesions from 2005 to 2019 with receipt of cape...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Matthew N., Naz, Afrin, Thawani, Chetna, Walker, Chelsea, Figura, Nicholas B., Kushchayev, Sergiy, Oliver, Daniel E., Etame, Arnold B., Yu, Hsiang-Hsuan Michael, Robinson, Timothy J., Liu, James K. C., Vogelbaum, Michael A., Forsyth, Peter A., Czerniecki, Brian J., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126143/
https://www.ncbi.nlm.nih.gov/pubmed/33992087
http://dx.doi.org/10.1186/s12885-021-08302-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126143/
https://www.ncbi.nlm.nih.gov/pubmed/33992087
http://dx.doi.org/10.1186/s12885-021-08302-9

Ejemplares similares